You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Philadelphia chromosome positive chronic myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

Not yet recruiting
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
  • (no location specified)
Jul 11, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

Active, not recruiting
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 2, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

Recruiting
  • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Beijing, China
    Peking University People's Hospital(北京大学人民医院)
Jan 3, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

Myeloid Leukemia, Philadelphia Positive Trial in Worldwide (Asciminib Pediatric formulation group, Asciminib Adult formulation

Recruiting
  • Myeloid Leukemia, Philadelphia Positive
  • Asciminib Pediatric formulation group
  • Asciminib Adult formulation group
  • Boston, Massachusetts
  • +24 more
Jan 17, 2023

Iclusig PMS in CML or Ph+ALL Patients

Recruiting
  • Chronic Myeloid Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Busan, Korea, Republic of
    Kosin University Gaspel Hospital
Sep 16, 2021

Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in France (Ponatinib, Imatinib)

Recruiting
  • Philadelphia Chromosome Positive CML
  • BCR-ABL Positive Chronic Myelogenous Leukemia
  • Amiens, France
  • +27 more
Dec 9, 2021

Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

Completed
Has Results
  • Philadelphia Chromosome Positive CML
  • imatinib mesylate
  • Chicago, Illinois
  • +9 more
Jun 3, 2021

Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Completed
  • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
  • Cairo, Egypt
    National Cancer Institute (NCI)
Feb 22, 2021

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

Completed
Has Results
  • Philadelphia Positive Chronic Myeloid Leukemia
  • +2 more
  • STI571 400 mg
  • STI571 600 mg
  • Boston, Massachusetts
  • +11 more
Jul 1, 2021

Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib + LDE225)

Completed
  • Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
  • Nilotinib + LDE225
  • Toronto, Ontario, Canada
  • +6 more
Dec 6, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021